Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stem cell
Biotech
ReNeuron leaving AIM exchange after missing fundraising goal
The stem cell biotech is letting go of its listing after money troubles persuaded it to free itself from the costs and obligations of the exchange.
Nick Paul Taylor
Aug 30, 2024 10:30am
Sickle cell gene therapy process may cause cancerous mutations
Nov 20, 2023 9:10am
Omeros saddles up for 2nd charge at transplant drug approval
Mar 14, 2023 9:30am
MaaT wraps up microbiome trial early to power into phase 2/3
Jan 24, 2022 7:20am
Magenta Therapeutics' research lead Davis hits the exit
May 27, 2021 10:40am
3 very different biotechs all file for an IPO
Apr 19, 2021 7:20am
